The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by ... whether exenatide use was associated with ...

"This large cohort study ... 0.83-1.25). "Because of GLP-1s' known side effect of pancreatitis, there's been some concern about links between GLP-1 use and pancreatic cancer. And this just shows ...

Its Phase 2b QUALITY trial evaluated the use of oral enobosarm in combination with semaglutide in a 168-patient randomized study ... default companion drug for quality GLP-1 fat loss.

On Thursday, though, officials at GIC and CVS Caremark, which manages state employee prescription drug ... GLP-1 and other drugs and use lifestyle management approaches. That model deserves more ...

The GLP-1 drug landscape ... FDA Makes a Big Shift on COVID Vaccine Policy ・Report: UnitedHealth Paid Nursing Homes to Keep Patients Out of Hospital ・'Definitely Cool' Study Digs Into Male ...

This difference from GLP-1 drug pharmacology ... dose study evaluating the safety, tolerability, and preliminary efficacy of RJVA-001 in adults with inadequately controlled T2D despite use of ...

And will it be enough to get manufacturers, brands and retailers to start taking the shift ... bankruptcy, shows there’s a very real chance some household names could face their own ‘Kodak moment’ if ...

Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are transforming India's health landscape. But without strong oversight, risks may out ...

“Our study shows that adoption of ... to foods than they did before GLP-1 use. “We know GLP-1s lessen the dopamine hit from food, making the experience less enjoyable, which could be why tastes start ...

With one in eight Americans having taken a GLP-1 already — including 43% of those with diabetes and a quarter of people with heart disease — it’s time to shift our thinking on GLP-1s to ...

The percentage of all commercially insured adult patients prescribed a GLP-1 drug ... use of behavioral health services decreased dramatically for patients prescribed GLP-1 drugs during the study ...